Clinical Trial Update: A Study of RG7314 to Investigate Efficacy and Safety in Individuals With Autism Spectrum Disorders (ASD) [Phase 2]

View source ↗

Summary

This update indicates that Roche's RG7314 Phase 2 trial in autism spectrum disorder has completed, evaluating its efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• RG7314

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED